apoptotic. About 41% of the WKY/Izm neurons died 1.5 hours after reoxygenation (necrosis = 12%, apoptosis = 29%). On the other hand, 78% of SHRSP/Izm neurons died (necrosis = 15%, apoptosis = 63%). Following three hours of reoxygenation, 99% of cells from both strains had died. In SHRSP/Izm rat neurons, fragmentation of DNA was strongly induced by 36 hours of hypoxia and reoxygenative stimulation for three hours (Tagami et al., 1998) . The H/R induced apoptosis of neuronal cells in SHRSP/Izm rats (Yamagata et al., 2010c) . The neuronal cells of SHRSP/Izm rats were strongly induced into apoptosis with 3 or 5 hours of reoxygenation following hypoxia. When DNA fragmentation was examined using a TUNEL method, few of the SHRSP/Izm rat neurons displayed DNA fragmentation when incubated under normal oxygen concentrations (data not shown). However, after 3 hours of reoxygenation following 36 hours of hypoxia, marked DNA fragmentation was seen. At the same time, many lipid droplets were detected in the cells (Tagami et al., 1998) . We classified the apoptotic levels in H/R conditions via a morphologic analysis of neuronal death (Tagami et al., 1998 (Tagami et al., , 1999 . We demonstrated the criteria for neuronal apoptosis in the SHRSP/Izm rats in Table 1 and Figure  1 . Neuronal axons and dendrites are lost in the early stages of apoptosis, and many lipid droplets are seen in the neuronal cell body (A, initial stage of apoptosis). Furthermore, cells shrink as apoptosis advances (B, second stage of apoptosis; C, third stage of apoptosis). The neuronal cell membrane is lost in the advanced stage of apoptosis, and the nucleus disappears (D). Figure 2 is considered to show the second stage of apoptosis (Tagami et al., 1998 : Yamagata et al., 2010c . These processes eventually lead to cell death. From these results, it is suggested that the neuronal weakness of SHRSP/Izm rats is associated with stroke development (Fig. 4) . A. initial stage, B, second stage, C. third stage and D necrosis (Tagami et al., 1998) www.intechopen.com Second stage The cells become round, small, and electrondense, and their nuclei demonstrate prominent invagination 3
Advanced stage The cells lose their cytoplasm and cell membrane, and their nuclei become small and dark before disappearing 4
Final stage The cells become electron-lucent, organelles decrease in number, and nuclei contain abnormal clusters of chromatin (the cells lose their cytoplasm and cell membrane, and their nuclei become small and dark before disappearing)
Cited references (Tagami et al., 1998 (Tagami et al., , 1999 . 
Gene expression of Bcl 2 and thioredoxin II in neuronal cells of SHRSP/Izm rats during H/R
The apoptosis in neuronal cells of SHRSP/Izm is strongly induced by reperfusion after ischemia (Tagami et al., 1998) . Simultaneously, oxidative stress can induce antioxidant enzymes in neuronal cells. Antioxidant enzymes can prevent the apoptosis caused by oxidation stress. Furthermore, the Bcl 2 gene is an oncogene related to human lymphoma and is able to inhibit the apoptosis induced by neurodegeneration stimuli (Akhtar et al, 2004) . We highlight that the Bcl 2 gene expression in SHRSP/Izm rat neuronal cells is significantly attenuated after 30 minutes of reoxygenation following hypoxia in comparison with that in WKY/Izm rats (Yamagata et al., 2000b) . The decrease in the expression of Bcl 2 leads to release of the cytochrome C from mitochondria. Thereafter, caspase activity increases and can strongly induce apoptosis. In SHRSP/Izm rat neurons, gene expression of thioredoxin II (Txn2) and mitochondrial cytochrome c oxidase III (CO III) decreased in a fashion similar to Bcl 2 30 minutes after reoxygenation following hypoxia (Yamagata et al., 2000b) . Txn2 provides protection against ROS via its SH group. In addition, these proteins have many functions that contribute to intracellular signal transduction. Namely, CO III is associated with energy metabolism in mitochondria. It transfers electrons from the reduced form of cytochrome C to molecular oxygen. Vitamin E and CO III are present in mitochondria where they protect the cell from injury by free radicals (Yang & Korsmeyer, 1996) . Attenuation of Bcl 2 and CO III gene expression in SHRSP/Izm rat neuronal cells may reduce energy metabolism and redox control during posthypoxic reoxygenation. The decrease of viability in SHRSP/Izm rat neurons, unlike that in WKY/Izm rat neurons, may be associated with their vulnerability.
Characteristics of SHRSP/Izm rat astrocytes during stroke
The functions of the astrocytes regulate outbreaks of cerebropathy (Chen & Swanson, 2003) . In brain lesions, reactive astrocyte numbers increase and promote the development of stroke (Pekny & Nilsson, 2005) . This characteristic of the astrocytes of SHRSP/Izm rats may be related to brain disease (Chen & Swanson, 2003) . We separated astrocytes from the brain of fetal SHRSP/Izm rats and cultured them. We compared the proliferation of astrocytes from WKY/Izm with SHRSP/Izm rats under various culture conditions (Yamagata et al., 1995) . The astrocytes isolated from fetuses are not influenced by blood pressure. We examined the characteristics of astrocytes from SHRSP/Izm rats in environments that were not influenced by blood pressure. We found that the growth of astrocytes from SHRSP/Izm rats was increased in comparison with those from WKY/Izm rats (Yamagata et al., 1995) . We suggest that the numbers of astrocytes of the SHRSP/Izm rats are increased and that this strongly leads to the gliosis following damage. In the rat brain transient cerebral ischemia model, epidermal growth factor (EGF) receptor is related to mechanism of astrocyte reactivity. The details are not known, but astrocyte numbers of SHRSP/Izm rats may increase by cell division through EGF stimulation during the appearance of cerebral blood vessel pathogenesis. This proliferation of astrocytes is enhanced by vascular smooth muscle cells in SHRSP/Izm rats (Yamori et al., 1981) . In fibrinoid necrosis degeneration by hypertension, the barrier function of endothelial cells diminishes and blood plasma components leak out of the circulation (Johansson, 1999) . In SHRSP/Izm rats, there is denaturation of smooth muscle cells of the media, necrosis with a rise in blood pressure, and destruction of the blood-brain barrier (BBB) in perforating branch arteries (Tagami et al.,1987) . We have indicated the possibility that attenuated endothelial barrier functions might be induced by comparing the astrocytic potency of SHRS/Izm rats (Yamagata et al., 1997b) . Glutamate is released as a neurotransmitter by nerve terminals and activates astrocytes. Furthermore, glutamate uptake via a glutamate transporter in the cell membrane is mediated by astrocytes. Glutamate produces lactate in astrocytes and the lactate produced by astrocytes is supplied as an energy source to neuronal cells (Pellerin & Magistretti 1994) . Concurrently, the lactate supplied by astrocytes is important for the recovery of the neuronal cells after ischemia (Schurr et al., 1997; Dringen et al., 1995) . We demonstrated that there is decreased lactate produced in cultured astrocytes from SHRSP/Izm rats when compared with that from WKY/Izm rat astrocytes during hypoxia (Yamagata et al., 2000a) . The decreased lactate production by SHRSP/Izm rat astrocytes may cause neuronal cell death through reduced energy supply. Furthermore, we examined characteristics of SHRSP/Izm rat astrocytes during stroke. In H/R, the expression levels of intercellular adhesion molecule-1 (ICAM1), monocyte chemotactic protein-1 (MCP1), and vascular cell adhesion molecule-1 (VCAM1) in astrocytes from SHRSP/Izm rats were increased in comparison with that in astrocytes from WKY/Izm rats (Yamagata et al., 2010a) . In addition, production of glial cell linederived neurotrophic factor (GDNF) by adenosine, H2O2, glutamate, sphingosine-1phosphate (S1P) was decreased during H/R in astrocytes from SHRSP/Izm rats in comparison with that from astrocytes from WKY/Izm rats (Yamagata et al., 2002;  2007a) ( Fig. 3) . Moreover, production of l-serine by nitric oxide (NO) stimulation decreased in SHRSP/Izm rats in comparison with that in WKY/Izm rats (Yamagata et al., 2006) . Not all of the differences seen in SHRSP/Izm rats compared with WKY/Izm rats may be related to the generation of neuronal dysfunction in SHRSP/Izm rats. However, decreased astrocytic lactate and GDNF production may worsen energy conditions and nutrition status of SHRSP/Izm rat neurons (Yamagata et al., 2008) . We suggest that attenuation of astrocyte functions accelerates neuronal cell death during stroke and may participate in its appearance ( Fig. 4 ). 
Endothelial dysfunction and importance of stroke prevention through nutrition
The risk of stroke increases with the presence of arteriosclerosis in cerebral blood vessel endothelial cells. Here, we describe preventive action for endothelial cell disorders by food components. The secretion of cytokines by initial lesions strongly activates endothelial cells, vascular smooth muscle cells, and blood cells. For example, endothelial cells are strongly influenced by the effects of inflammatory cytokines such as tumor necrosis factor alpha (TNF-) and interleukin beta (IL-1) (Kofler et al., 2005) . As a consequence, monocytic adhesion to endothelial cells is induced, which promotes various arteriosclerotic processes. Among these, the oxidative stress produced during the early period of the disorder triggers arteriosclerosis. When the various arteriosclerotic reactions begin simultaneously, they are very difficult to inhibit. Therefore, it is best to inhibit ROS production in the early stages of the disorder in order to avoid arteriosclerosis (Kondo et al., 2009) . Indeed, the effects of nutritional components with antioxidant activity on the redox regulation of ROS in stroke conditions have been reported previously. It is considered to be possible to inhibit blood vessel disorders in the early stages and that the inhibition of ROS production using polyphenols prevents the development of arteriosclerosis (Manach et al., 2004) . Therefore, it is very likely that arteriosclerosis prevention via the consumption of appropriate foods such as antioxidant nutrients can be used to reduce the risk of stroke.
Possible role of polyphenols against cerebral ischemia injury
Cerebral ischemia induces the rapid production of a large quantity of ROS and induces cell injury through self-perpetuating reactions. Free radicals are produced within several minutes of reoxygenation after cerebral ischemia and induce brain cell injury (Bolli, 1991) . Cerebral ischemia elevates the intracellular level of calcium ions and activates calciumwww.intechopen.com dependent proteases. Moreover, these reactions activate xanthine dehydrogenase (XDH) and produce xanthine oxidase (XOD) (Thompson-Gorman & Zweier, 1990) . It is considered that the superoxide anion radicals produced via this pathway cause neuronal death. However, the consumption of polyphenol-rich foods, such as fruits and vegetables, is beneficial for preventing vascular disorders (Manach et al., 2004) . Epidemiological studies have indicated that an inverse correlation exists between polyphenolic consumption and the risk of having to undergo a cardiovascular procedure (Arts & Hollman, 2005) . Polyphenols induce the production of vasodilatory factors such as NO (Auger et al., 2010) and prostacyclin (PGI 2 ) (Mizugaki et al., 2000) and inhibit the synthesis of endothelin-1, which induces vasoconstriction in endothelial cells (Reiter et al., 2010) . On the other hand, the polyphenols present in the skin of grapes and in wine inhibit the proliferation and migration of smooth muscle cells (Lee et al., 2009) . Polyphenols may eliminate the active oxygen produced by reoxygenation after cerebral ischemia via their antioxidative effects.
Vasorelaxant effects of polyphenols on endothelial cells
Epidemiological analysis has suggested that polyphenols have protective effects against heart disease. The polyphenols that protect against heart disease are found in foods including cocoa, wine, grape pips, berries, tea, tomatoes, soybeans, and pomegranates (Chong et al., 2010) . The mechanisms by which polyphenols reduce the risk of heart disease are associated with the prevention of endothelial cell disorders. Endothelial cell disorders strongly induce arteriosclerosis, which subsequently progresses to heart disease and stroke. Therefore, the prevention of endothelial cell disorders by polyphenols is effective in preventing heart disease and stroke. Table 2 shows the effects of the typical polyphenols apigenin, EGCG, and resveratrol on endothelial cells. Jin et al. (2009) demonstrated that apigenin (0.5 -72.0 M) enhanced concentration-dependent relaxation in aortas. Apigenin action is mediated by weakening the oxidative stress and by NO reduction. On the other hand, it has been shown that stimulation of expression of endothelial NOS (eNOS) by apigenin occurs through phosphatidylinositol 3-kinase/Akt (PI3K/Akt) for Ca 2+ dependence . Moreover, the blockade of adhesion of monocytes and cyclooxygenase (COX)-2 expression in endothelial cells by apigenin has been reported (Lee et al., 2007) . We have shown that apigenin strongly inhibits high glucose-and TNF--induced VCAM1 expression and the adhesion of U937 in human endothelial cells (Yamagata et al., 2010b) . These effects of apigenin are caused by the inhibition of Iionkinase (IKK)  and IKK/IKKi. From these findings, we suggested that the mechanism by which apigenin inhibits the expression of adhesion molecules and the adhesion of monocytic U937 to endothelial cells involves nuclear factor kappa beta (NF-). From the structure and inhibitory activity profiles of dietary flavonoids, it was recognized that the double bond found in the C-ring of flavonoids and the third hydroxyl group (A-ring) are required for the inhibition of VCAM1 gene expression (Yamagata et al., 2010b) . Apigenin may inhibit monocytic adhesion caused by superoxide anions as well as block reductions in NO activity. From these reports, it is considered that apigenin reduces the levels of ROS, promotes NO activity, and inhibits cell adhesion. Moreover, apigenin strongly inhibited the TNF-stimulated expression of lectin-like oxidized low-density lipoprotein receptor-1 (LOX-1) (Yamagata et al., 2011) and the double bond of the C ring of apigenin is essential for this action (Fig. 5 ). As shown in Figure. 5, the inhibition of LOX-1 expression by apigenin requires a flavone frame, a double bond in the C-ring, and the absence of a third hydroxyl group in the Band C-rings, which are not found in naringenin (not active) (Yamagata et al., 2011) .
Polyphenol(s) Effects on pathological condition(s) Ref (authors and issue) Apigenin
Endothelium Lee et al., (2010) Protects against oxidized LDL-induced endothelial dysfunction by inhibiting LOX-1-mediated signaling Ou et al., (2010) Decreases thrombin/paclitaxel-induced endothelial tissue factor expression Wang et al., (2010) inhibiton of angiotensin II-induced endothelial barrier dysfunction Yang et al., (2010) www.intechopen.com Lin et al., (2010) COX; cyclooxygenase, GPx1; glutathione peroxidase 1, I/R; ischemia/reperfusion, LDL; low density lipoprotein, LOX-1; lectin-like oxidized low-density lipoprotein receptor-1, MCP-1; monocyte chemotactic protein-1, NO; nitric oxide, Nox4; NADPH oxidase subunit, PAF; platelet-activating factor, SOD1; superoxide dismutase 1, SHR, spontaneously hypertensive rats, TNF; tumor necrosis factor, VEGF; vascular endothelial growth factor, Table 2 . Studies on the protective effects of apigenin, EGCG and resveratrol in endothelial cells EGCG is a catechin that is found in green tea. The catechins found in tea include epicatechin (EC), epigallocatechin (EGC), epicatechin gallate (ECG), and epigallocatechin gallate (EGCG), and the content order of these compounds is as follows: EGCG>EGC>ECG>EC. Catechins are also responsible for the bitter taste of green tea. Catechins account for around 13%-30% of the dry weight of tea leaves (Wolfram, 2007) . EGCG suppresses the expression of adhesion molecules such as MCP1 (Ahn et al., 2008; Chae et al., 2007; Hong et al., 2007) and expression of endothelin-1 (Reiter et al., 2010) . Like apigenin, EGCG inhibits the expression of monocyte adhesion molecules in endothelial cells stimulated with TNF- (Ahn et al., 2008; Zheng et al., 2010) and it has been reported that EGCG inhibits the TNF-induced expression of activator protein-1 in endothelial cells and increased the expression of HO-1. These findings suggest that EGCG inhibits the expression of activator protein-1 and increases the expression of HO-1, both of which aid endothelial protection. Furthermore, a least one study demonstrated that EGCG downregulated the endothelial cell activation induced by linoleic acid via caveolin-1 (Zheng et al., 2009) . Six hours of linoleate exposure induced the expression of caveolin-1 and COX-2 in caveolae. However, pretreatment with EGCG inhibited the expression of caveolin-1 and COX-2 induced by linoleic acid. Exposure to linoleic acid also increased the levels of several kinases (p38 MAPK, extracellular signal regulated kinase 1/2 8ERK1/2), and amino kinase terminal (Akt). According to these findings, EGCG activates several enzymes in endothelial cell caveolae and may have many preventive effects for vascular disorders. Many studies have demonstrated that ischemic heart disease is decreased by wine intake, and in particular, it has been shown that the antioxidative effects of the polyphenols found in red wine are important for cardioprotection. It was shown that this cardioprotective effect is caused by the actions of resveratrol. It has been confirmed that resveratrol displays various pharmacologic actions such as antioxidant activity in humans (Brito et al., 2006; Chow et al., 2007; Spanier et al., 2009; Ungvari et al., 2009) . Resveratrol is considered to decrease circulating low-density lipoprotein (LDL) cholesterol levels and thereby reduce the risk of cardiovascular disease (CVD) (Ramprasath & Jones, 2010) . Resveratrol inhibits atherosclerosis and improves the function of endothelial cells in animal models. There have been many studies of resveratrol actions, which have shown that it has various effects on endothelial cells, as shown in Table 2 . The effects of resveratrol and red wine on endothelial cells were investigated using experimental hypercholesterolemic rabbits (Zou et al., 2003) . It was found that hypercholesterolemic rabbits displayed significant improvements in the functions of their endothelial cells after the administration of resveratrol (3 mg/kg/day), red wine (4 ml/kg/day), or nonalcoholic red wine (4 ml/kg/day) for 12 weeks. Moreover, they demonstrated decreased levels of plasma endothelin-1 and NO, which are increased by hypercholesterolemia. On the other hand, it was also shown that resveratrol protects against injury to the BBB caused by oxidized LDL (oxLDL) (Lin et al., 2010) . It is considered that the mechanism behind these effects of resveratrol involves amelioration of the effects of oxLDL on the expression of occludin and ZO-1, which aids the stability of tight junctions. Resveratrol regulates the expression of tight junction proteins as a means of protecting against the disruption of the BBB induced by oxLDL. In a rat postischemic reoxygenation model, resveratrol decreased ROS generation (Shigematsu et al., 2003) , and the effect of resveratrol on cerebral infarction was also examined in a rat middle cerebral artery occlusion (MCA) model (Sinha et al., 2002) . In addition, after MCA and 2 hours of reperfusion, the rats were evaluated for motor disorders, malondialdehyde (MDA), reduced glutathione, and infarct volume. After MCA, increases in the frequency of functional motility disorders and the levels of MDA and reduced glutathione were observed. On the other hand, the administration of resveratrol prevented these increases and significantly decreased the infarct volume. These findings indicate that resveratrol inhibits the organ injuries produced by ischemia-reperfusion. The other polyphenols found in wine are not known to have this effect. Correspondingly, resveratrol prevents myocardial infarction by reducing peroxide levels. It is suggested that this effect can be attributed to the antioxidative effects of resveratrol (Dudley et al., 2008) .
Preventive effects of antioxidant drugs and polyphenols for SHRSP rat neurons during stroke
We indicated that high dose vitamin E induced neutral gamma glutamylcystenyl synthase (-GCS), GSH levels, and strongly prevented neuronal death (Yamagata et al., 2009 ). Furthermore, we have shown that ebselen, a seleno-organic antioxidant (Yamagata et al., 2008) , amlodipine, and carvedilol (Yamagata et al., 2004) prevented neuronal cell death in SHRSP/Izm rats. Another study demonstrated that the expression of VCAM1 by TNF- in astrocytes isolated from SHRSP/Izm rats was increased compared with that in those from WKY/Izm rats. However, apigenin strongly attenuated TNF--induced VCAM1 mRNA and protein expression and suppressed the adhesion of U937 cells and SHRSP/Izm astrocytes (Yamagata et al., 2010a) . It is suggested that apigenin regulates adhesion molecule expression in reactive astrocytes during ischemia and prevents neuronal death.
Conclusion
Endothelial cell dysfunction causes arteriosclerosis and promotes neuronal demise after stroke. Enhanced neuronal sensitivity to oxidative stress contributes to the neuronal death observed in SHRSP/Izm rats. Also, enhanced oxidative stress after hypoxia-reoxygenation is important in ischemic stroke. Polyphenols reduce oxidation stress and have a protective effect on endothelial and neuronal cells. Antioxidant nutrients such as polyphenols may prevent or reduce endothelial dysfunction and neuronal cell injury during cerebral ischemia.
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